16-28502022-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145659.3(IL27):c.416C>A(p.Ala139Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145659.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL27 | NM_145659.3 | c.416C>A | p.Ala139Asp | missense_variant | 4/5 | ENST00000356897.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL27 | ENST00000356897.1 | c.416C>A | p.Ala139Asp | missense_variant | 4/5 | 1 | NM_145659.3 | P1 | |
IL27 | ENST00000568075.1 | c.23C>A | p.Ala8Asp | missense_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249940Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135228
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460060Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726428
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.416C>A (p.A139D) alteration is located in exon 4 (coding exon 4) of the IL27 gene. This alteration results from a C to A substitution at nucleotide position 416, causing the alanine (A) at amino acid position 139 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at